| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $64,246,748 ) (Continued on the next page) |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K12AR084228 | UTMB Women's Health Research Scholars Program | 002 | 21 | NIH | 6/5/2024 | $1 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K12AR084228 | UTMB Women's Health Research Scholars Program | 002 | 21 | NIH | 6/5/2024 | $283,681 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI175955 | Role of Hypoxia-Inducible Factors (HIFs) in Respiratory Syncytial Virus Infection | 000 | 2 | NIH | 5/7/2024 | $200,000 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM150459 | Dynamic regulatory impact of human transposable elements on gene expression | 000 | 2 | NIH | 4/26/2024 | $387,465 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI171664 | PIWIL4 and piRNAs in RSV Infection | 001 | 2 | NIH | 5/17/2024 | $20,000 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI171664 | PIWIL4 and piRNAs in RSV Infection | 000 | 2 | NIH | 1/17/2024 | $180,000 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM148364 | Mechanisms for the high fidelity of translesion synthesis by Y-family DNA polymerases in human cells | 001 | 2 | NIH | 6/21/2024 | $43,180 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM148364 | Mechanisms for the high fidelity of translesion synthesis by Y-family DNA polymerases in human cells | 000 | 2 | NIH | 11/9/2023 | $388,626 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R61AG075725 | tRNA-derived RNA Fragments (tRF) as Prognostic and Diagnostic Biomarkers for Alzheimer’s Disease | 000 | 2 | NIH | 2/23/2024 | $799,998 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG081282 | Nursing homes' visitation bans during the COVID-19 pandemic: Effectiveness and consequences. | 002 | 2 | NIH | 6/10/2024 | $34,635 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG081282 | Nursing homes' visitation bans during the COVID-19 pandemic: Effectiveness and consequences. | 001 | 2 | NIH | 1/31/2024 | $311,715 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01HD113193 | Investigating the molecular mechanism of P-gp/NHERF-1 network at feto maternal interface and role of paracrine signaling of EVs containing drug transporter proteins | 000 | 2 | NIH | 6/4/2024 | $277,200 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01HD110400 | Developing trimester-specific placenta organ-on-chips to model healthy and oxidative stress and inflammation-associated pathologies | 000 | 2 | NIH | 5/3/2024 | $483,870 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01EY034616 | Anti-Aging Molecule Sirt6 in Neuroprotection in Diabetic Retina | 000 | 2 | NIH | 5/21/2024 | $541,883 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K99AI168484 | Assessing the roles of viral mutations and host factors in the transmission of Mayaro virus and other alphaviruses by urban mosquitoes | 000 | 2 | NIH | 4/22/2024 | $119,264 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AG082389 | Does Vision Loss Affect Tauopathy in the Brain | 000 | 2 | NIH | 4/24/2024 | $200,000 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AG082230 | Role of microglia in cognitive resilience to AD | 001 | 2 | NIH | 6/28/2024 | $12,000 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AG082230 | Role of microglia in cognitive resilience to AD | 000 | 2 | NIH | 2/1/2024 | $108,000 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AG081900 | Comparative effectiveness of pelvic floor muscle training, Mirabegron, and Trospium among older women with urgency urinary incontinence and high fall risk: a feasibility randomized clinical study. | 001 | 2 | NIH | 4/18/2024 | $193,067 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS128410 | Role of Primary Sensory Neuron CaMKII Signaling in Regulation of Pain | 001 | 2 | NIH | 6/26/2024 | $629,263 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01GM145925 | Mitochondrial translesion DNA synthesis | 001 | 2 | NIH | 6/24/2024 | $33,375 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U24FD007821 | An Educational Program to Enhance Data Quality and Integrity for Regulated Studies Supporting the Advancement of Medical Countermeasures for High Consequence Pathogens | 000 | 2 | FDA | 12/12/2023 | $480,000 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01GM145925 | Mitochondrial translesion DNA synthesis | 000 | 2 | NIH | 3/20/2024 | $300,371 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R00AI156012 | Viral factors responsible for Lassa virus pathogenicity | 001 | 4 | NIH | 3/15/2024 | $249,000 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01ES033682 | Hepatic Aryl Hydrocarbon Receptor Regulation of Obesity: Mechanisms of Action | 000 | 3 | NIH | 6/24/2024 | $356,219 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K01AG075254 | Gender Disparities in Pain and Treatment and their Association with Alzheimer's Disease and Related Dementias (ADRD) | 000 | 3 | NIH | 7/19/2024 | $123,750 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI178318 | Targeting HNF4-induced thrombo-inflammation in Chagas disease | 001 | 2 | NIH | 7/23/2024 | $20,882 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01EY034376 | CXCR3-Mediated Cell-Cell Communication in Glaucoma | 000 | 3 | NIH | 7/18/2024 | $430,917 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21EB034033 | White matter tract-specific near-infrared fluorescence probes for in vivo fluorescence guided white matter tractography | 000 | 3 | NIH | 6/11/2024 | $200,625 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | 90IFRE0079 | Interplay of Physiological, Psychosocial, and Functional Outcomes in Burn Survivors. | 00 | 2 | ACL | 6/5/2024 | $199,987 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | T0839277 | Scholarships for Disadvantaged Students | 00 | 5 | HRSA | 5/24/2024 | $650,000 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R03HD108495 | Developing IL-10 encapsulated exosomes as novel therapeutics for spontaneous preterm birth | 001 | 2 | NIH | 5/7/2024 | $8,000 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R03HD108495 | Developing IL-10 encapsulated exosomes as novel therapeutics for spontaneous preterm birth | 000 | 2 | NIH | 11/8/2023 | $72,000 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH132226 | Probing brain circuit and behavior with protein:protein interaction modulators | 000 | 2 | NIH | 11/29/2023 | $714,809 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG068988 | The influence of social and cultural context on life course pathways for Alzheimer's disease, related dementias, and care resources for older Mexican adults | 000 | 2 | NIH | 7/18/2024 | $319,286 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K01NS137812 | Tunneling nanotubes are a novel mechanism for the propagation of HIV infection and neurodegeneration | 000 | 1 | NIH | 7/18/2024 | $197,345 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R61AI179997 | Generation of Orientia tsutsugamushi mutant strains for pathogenesis research | 000 | 1 | NIH | 12/15/2023 | $280,000 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R25HL161715 | The University of Texas Medical Branch Summer Institute in Biostatistics and Data Science (UTMB-SIBDS) | 000 | 3 | NIH | 1/12/2024 | $179,745 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R25HL161715 | The University of Texas Medical Branch Summer Institute in Biostatistics and Data Science (UTMB-SIBDS) | 000 | 3 | NIH | 1/12/2024 | $75,000 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS125778 | Role of microglia in neural infection | 001 | 3 | NIH | 5/3/2024 | $36,123 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS125778 | Role of microglia in neural infection | 000 | 3 | NIH | 12/7/2023 | $464,451 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI158422 | Ehrlichia Notch SLiM-activated oncoprotein inhibition of apoptosis | 001 | 3 | NIH | 5/15/2024 | $40,000 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI158422 | Ehrlichia Notch SLiM-activated oncoprotein inhibition of apoptosis | 000 | 3 | NIH | 11/3/2023 | $360,000 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG075208 | Identifying the Causes of the Stagnation in National U.S. Cardiovascular Disease Mortality | 001 | 2 | NIH | 6/25/2024 | $37,226 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG075208 | Identifying the Causes of the Stagnation in National U.S. Cardiovascular Disease Mortality | 000 | 2 | NIH | 1/18/2024 | $335,034 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI176297 | Nanoparticle-encapsulated Epigenetic Inhibitors for Treatment of Inflammatory Bowel Diseases | 000 | 1 | NIH | 1/29/2024 | $214,129 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI176297 | Nanoparticle-encapsulated Epigenetic Inhibitors for Treatment of Inflammatory Bowel Diseases | 001 | 1 | NIH | 2/22/2024 | $0 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI176670 | Porous silicon microparticle-based subunit vaccines for SARS-CoV-2 | 001 | 2 | NIH | 5/23/2024 | $67,120 |
| 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI176670 | Porous silicon microparticle-based subunit vaccines for SARS-CoV-2 | 000 | 2 | NIH | 1/18/2024 | $604,067 |
|